François Bordeleau
Chercheur universitaire
Axe Oncologie
Génie médical et biomédical
Métastases et progression du cancer
Génie des tissus artificiels
Génétique quantitative
Physique atomique, moléculaire et optique
Nanobiotechnologies
Études sur le cytosquelette
Interactions cellulaires
Biotechnologies médicales
Signalisation intracellulaire, transduction des signaux, biologie des récepteurs et des membranes
Diagnostics faisant appel aux biotechnologies médicales
Biologie cellulaire computationnelle
Médecine régénérative
Génomique
Tumeurs cancéreuses solides
Publications
View all-
article Brownell D, Carignan L, Alavi R, Caneparo C, Labroy M, Galbraith T, Chabaud S, Berthod F, Gibot L, Bordeleau F, Bolduc S
Impact of the Use of 2-Phospho-L Ascorbic Acid in the Production of Engineered Stromal Tissue for Regenerative Medicine
Cells 14 (14), 2025.
-
article Alavi R, Chancy O, Trudel B, Dewit L, Luthold C, Piquet L, Akbarzadeh A, Desjardins M, Landreville S, Bordeleau F
Quantitative polarization microscopy as a potential tool for quantification of mechanical stresses within 3D matrices
Acta Biomater 200 2025.
-
article Prifti DK, Lauzier A, Garand C, Calvo E, Devillers R, Roy S, Dos Santos A, Descombes L, Trudel B, Laplante M, Bordeleau F, Elowe S
ARHGEF17/TEM4 regulates the cell cycle through control of G1 progression
J Cell Biol 224 (3), 2025.
Projects
- Protein glycation acts as a substrate-dependent tumorigenic molecular switch in prostate cancer, from 2022-04-01 to 2027-03-31
- Creating a biomimetic 3D engineered model of the liver metastatic niche, from 2024-03-31 to 2026-03-30
- Canada research chair Tumor Mechanobiology and cellular Mechanoregulation, from 2025-07-01 to 2030-06-30
- Validation d’une signature d’épissage alternatif mécano-dépendante pour prédire de manière précoce les risques de progression du cancer du sein vers un stade métastatique, from 2025-03-01 to 2027-03-31
- Bourse de soutien aux nouveaux détenteurs de Chaire de recherche du Canada, from 2025-07-01 to 2029-06-30
- FGR-Development of 3D engineered tissues as alternative to in vivo models, from 2025-07-22 to 2026-07-21
- The combined role of cellular force dynamics and extracellular matrix mechanical properties in driving angiogenesis, from 2018-04-01 to 2025-03-31
- Canada Research Chair in Tumor Mechanoregulation, from 2020-07-01 to 2025-06-30
- Programme de soutien aux nouveaux détenteurs de CRC, from 2022-05-01 to 2024-04-30
- Hepatic stellate cells as a driver of the pre-metastatic niche in uveal melanoma, from 2023-03-01 to 2024-02-29
- Mise en place de la plateforme d'ingénierie tissulaire en cancer, from 2023-09-01 to 2025-12-31